Pharma R&D Today

Drug Companies Collaborate to Take on the Opioid Crisis

Posted on November 8th, 2017 by Betsy Davis in Pharma R&D

The opioid crisis in the US is now responsible for taking more American lives each year than car crashes. (more…)

Snakes (aka Chutes) and Ladders – failures and opportunities

Posted on October 13th, 2017 by Dr Andrew A. Parsons in Pharma R&D

If there ever was a children’s game that would help prepare the next generation of pharmaceutical R&D scientists and researchers, it would be Snakes and Ladders (Chutes and Ladders in the US). (more…)

Getting Personal: Better Diagnosis, Better Treatment

Posted on September 8th, 2017 by Betsy Davis in Pharma R&D

Figures released by the U.S. National Cancer Institute (NCI) in 2017 indicate that the burden of cancer is on the rise, with the number of diagnoses rising by 50% over the next 13 years. Even more troubling is the predicted mortality rate for cancer, (more…)

FDA Speeds Up Generic Approval Process

Posted on August 30th, 2017 by Xuanyan Xu in Pharmacovigilance

Healthcare has been in the spotlight for much of the year so far, as Congress has wrestled with the difficult question of how to make it both better and more affordable.

(more…)